Youngsin Metal Industrial Co., Ltd. (KOSDAQ:007530)

Revance Therapeutics Revenue

Youngsin Metal Industrial had revenue of 43.67B KRW in the quarter ending March 31, 2025, with 1.91% growth. This brings the company's revenue in the last twelve months to 173.02B, up 2.81% year-over-year. In the year 2024, Youngsin Metal Industrial had annual revenue of 172.20B with 3.55% growth.

• Revenue (ttm): 173.02B
• Revenue Growth: +2.81%
• P/S Ratio: 0.34
• Revenue / Employee: 476.64M
• Employees: 363
• Market Cap: 59.46B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	172.20B	5.91B	3.55%
Dec 31, 2023	166.29B	19.97B	13.65%
Dec 31, 2022	146.32B	23.45B	19.08%
Dec 31, 2021	122.87B	12.30B	11.13%
Dec 31, 2020	110.57B	-9.21B	-7.69%